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Cells respond to DNA damage during S phase by
slowing chromosome replication. Recent results have
shed light on the mechanism by which this ‘intra-S
phase’ checkpoint is implemented.
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Damage to chromosomes is potentially catastrophic, and
cells are never more vulnerable than when in the process
of replicating their DNA. Lesions caused by DNA-modi-
fying agents, such as the alkylating agent methyl methane-
sulphonate (MMS), must be repaired before the DNA is
copied, to prevent the replication machinery pairing an
incorrect base with the modified one. Other agents, such
as hydroxyurea, have the potential to damage chromo-
somes by interfering directly with the progress of replica-
tion forks, leading to incomplete replication and subsequent
chromosome breakage. Cells respond to such problems
encountered during chromosome replication by slowing
progression through S phase, as a consequence of activat-
ing a checkpoint mediated by the Rad53 and Mec1 pro-
teins [1]. Two recent papers [2,3] give the first picture of
how this ‘intra-S checkpoint’ is enacted. These studies
reveal a two-pronged cellular response, with existing repli-
cation forks being stabilised, whilst unfired replication
origins are prevented from initiating new replication forks.
As DNA-damaging drugs are used in cancer chemother-
apy, understanding the cellular response to them may lead
to more effective treatment regimes. 
Initial work on the intra-S checkpoint showed that when
yeast cells were treated with MMS progress through S
phase was retarded [1]. That this retardation was due to a
cellular checkpoint, rather than simply non-specific inhibi-
tion of the replication machinery, was demonstrated by
examining cells deficient in mec1 and rad53, two classic
checkpoint genes. Mutants for either gene appeared to
complete replication of MMS-damaged DNA at almost
normal speeds, as assessed by flow cytometry. In an undis-
turbed S phase, replication origins are activated according
to a predetermined programme, with some initiating repli-
cation early and others late in S phase. Two subsequent
papers [4,5] showed that, when they are exposed to MMS,
checkpoint-proficient yeast cells initiate replication from
early origins, but then pause the temporal programme and
do not activate late replication origins. The rad53 and mec1
mutants were found to be incapable of this late origin
repression; when treated with MMS they still proceed
with initiation at late origins. This observation was consis-
tent with work on mammalian cells showing that DNA
alkylation can lead to a specific inhibition of initiation
from other origins [6,7]. But is inhibition of late origin
firing sufficient to explain the Rad53/Mec1-mediated delay
in S phase progression, or is the rate of movement of exist-
ing replication forks also affected?
Checkpoint-independent slowing of replication forks on
damaged DNA
Tercero and Diffley [2] have addressed this question by
using a modification of the classic Meselson and Stahl [8]
density substitution technique to monitor the replication
timing of different chromosome segments in yeast. They
found that, in the presence of MMS, replication forks
indeed proceed only extremely slowly — at about 300 base
pairs per minute, compared to approximately 3000 base
pairs per minute in an undisturbed S phase (Figure 1a,b).
But this fork slowing did not require the Rad53/Mec1
checkpoint — forks in rad53 and mec1 mutant cells moved
just as slowly in the presence of MMS (Figure 1c). This
result implies that the failure of rad53/mec1 checkpoint
mutants to slow S phase progression in MMS does not
arise from faster fork progression, but is instead entirely
due to their inability to repress late origins. 
There was, however, a crucial change in the behaviour of
the replication forks in the absence of Rad53 or Mec1.
Although forks replicating MMS-damaged DNA in wild-
type cells progressed very slowly, they did make steady
progress, copying the DNA at about the same overall rate
over 4 hours. But in rad53 and mec1 mutants exposed to
MMS, an increased proportion of replication forks appeared
to stall irreversibly or collapse completely: origin-proximal
sequences were efficiently replicated, but sequences further
away were replicated in only a proportion of cells. 
Checkpoint genes prevent accumulation of abnormal DNA
structures at stalled forks
An accompanying paper by Lopes et al. [3] sheds light on
the nature of the irreversible fork stalling in the checkpoint
mutants. This study examined forks stalled by hydroxyurea,
a drug that blocks ribonucleotide reductase and hence
reduces the availability of dNTP precursors needed for
DNA synthesis. Lopes and co-workers used a two-dimen-
sional agarose gel technique that allows examination of the
replication intermediates present in any DNA fragment of
interest [9]. They found that, in wild-type cells treated with
hydroxyurea, most replication forks arrested close to the
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replication origin. When hydroxyurea was subsequently
removed, these forks then resumed replication and moved
away from the origin region. In rad53 mutant cells treated
with hydroxyurea, fewer replication forks were apparent,
but instead replication intermediates were seen in positions
corresponding to X and small Y-shaped molecules. 
Although the exact pathway by which they arise is not
known, such X-shaped and small Y structures are believed
to result when stalled replication forks collapse and undergo
abnormal DNA processing events, such as may occur
during abortive recombinational repair [10]. Subsequent
removal of hydroxyurea in rad53 mutants did not result in
the resumption of replication and consequent disappear-
ance of these intermediates. The abnormal structures
instead appear to be unrepairable, consistent with the pre-
vious observation that rad53 mutant cells are unable to
recover from a hydroxyurea block.
Coordination of replication fork traffic
The effects of MMS and hydroxyurea on checkpoint-
mutant cells suggest that a Rad53/Mec1-dependent
pathway (preventing fork collapse) is enacted by both
treatments. It seems unlikely, however, that collapse of a
single replication fork is a lethal event, because the DNA
lying between two origins can potentially be replicated by
a fork from either origin. If one fork collapses, the fork
from the neighbouring origin should simply carry on repli-
cating the intervening DNA until it eventually encounters
the collapsed fork. DNA replication will only fail if both
forks converging from adjacent origins collapse before
they meet (see Figure 1c). 
From the observed rates of replication fork collapse in
rad53 or mec1 mutant cells in MMS, Tercero and Diffley
[2] calculate that such double fork collapse would occur in
approximately 16% of replicons. Given that yeast cells
have about 400 origins, some such occurrences are a virtual
certainty for rad53 or mec1 cells treated with MMS, and
will doom the cells as they attempt mitosis, because
chromosomes with unreplicated sections cannot be prop-
erly segregated. If such increased fork collapse is the cause
of the extreme sensitivity of rad53/mec1 mutants to MMS,
then one prediction is that the sensitivity to MMS will be
mitigated if the cells are prevented from attempting S
phase. Tercero and Diffley [2] tested this possibility
directly, and were able to show that the extreme toxicity of
MMS to checkpoint mutants was alleviated if cells were
exposed to MMS only while in G1 or G2.
These important findings as usual raise a new set of inter-
esting questions. One concerns the immediate cause of
Figure 1
Replication defects caused by DNA damage
in cells mutant for the intra-S phase
checkpoint. Grey circles represent early
origins and black circles late origins.
(a) Progress of normal chromosome
replication. (b) Replication of chromosomes
damaged by MMS. Replication forks proceed
much more slowly than normal but are stable
and not subject to collapse. Repression of late
origin activation depends directly or indirectly
on Rad53 and Mec1. (c) Replication of MMS-
damaged chromosomes in rad53 or mec1
mutants. Replication forks proceed as slowly
as in wild-type cells subject to DNA damage.
Late origins are activated, and replication forks
are unstable, with about 40% stalling
irreversibly or collapsing (red T shapes), so
that some DNA regions cannot be replicated.
Dotted arrows indicate that the S phase
period is extended even more than illustrated
here: S phase is complete within 1 h under
normal circumstances, but lasts more than 3 h
in the presence of MMS.
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the replication fork slowing seen when the DNA of either
wild-type or rad53/mec1 mutant cells is damaged. As it is
now clear that the fork slowing does not depend on the
Rad53/Mec1 checkpoint, the question arises as to whether
a different (unidentified) checkpoint pathway is responsi-
ble, or whether instead the observed fork slowing results
from a physical block to polymerase passage posed by
alkylation damage. The relatively constant rate of fork
collapse observed by Tercero and Diffley [2] could be
consistent with a physical impediment to fork passage
posed by damage incurred at a relatively constant density
within the DNA. While we favour this model, current
data cannot preclude the action of an unidentified fork-
slowing checkpoint.
Another outstanding issue is the mechanism by which the
Mec1/Rad53 checkpoint pathway stabilises replication
forks, and whether it is related to the mechanism by which
Rad53 appears to regulate intracellular dNTP pools [11].
The target of the Mec1/Rad53 pathway in preventing
collapse of stalled replication forks remains obscure. It is
possible that there are targets of the intra-S checkpoint
both at stalled forks, to stabilise them against breakdown,
and at late origins, to prevent their inappropriate activation
(see Figure 2a). Multiple sites of action of the checkpoint
during S phase could explain the assignment of several
different gene products as likely targets, including at
replication forks the single-stranded DNA-binding protein
RP-A [12,13] and the polymerase α-primase complex [14],
and at late origins Dbf4, the activator of the Cdc7 protein
kinase (reviewed in [15]). 
Alternatively, the primary function of the Rad53/Mec1
checkpoint could be the stabilisation of replication forks.
The effect on late-firing origins could then be caused by
these stabilised forks generating a distinct signal — not
directly dependent on Rad53 or Mec1 — which represses
late origin activation (Figure 2b). Either of these two
possible mechanisms might make physiological sense of
the existence of late origins: they could be regarded as
‘back-up’ initiation sites in the event that replication from
early origins is unsuccessful. If cells are encountering
general problems with progression of forks from early
origins, it would make sense to postpone recourse to the
back-up late initiation sites until either the replication
interference has been removed (such as when MMS or
hydroxyurea is withdrawn from the experiment) or else if
the existing forks have failed irretrievably, after which
they are proposed no longer to generate the signal to
inhibit late origin activation.
These interpretations could potentially explain the relative
sensitivity of cancer cells to chemotherapeutic DNA-dam-
aging agents. As they frequently have defective checkpoint
pathways, cancer cells might be unable to benefit fully
from the intra-S phase checkpoint: neither being able to
stabilise stalled replication forks nor being able to hold late-
firing origins in reserve whilst DNA damage is occurring.
Failure of either or both these arms of the intra-S phase
checkpoint could severely compromise the capability of
cancer cells to deal with damage to their chromosomes. 
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